What Researchers Did
Researchers reviewed 18 years of patient cases at a single medical center to compare outcomes for craniocervical necrotizing fasciitis (CCNF) with and without spread to the chest.
What They Found
Out of 20 patients with CCNF, those whose infection spread to the chest had a 60% survival rate (6 out of 10), while all 10 patients without chest involvement survived. Three patients with chest involvement received hyperbaric oxygen therapy, and 66% of this small group survived.
What This Means for Canadian Patients
Canadian patients diagnosed with craniocervical necrotizing fasciitis, particularly if the infection has spread to the chest, may face a more challenging recovery. This study highlights the importance of prompt and aggressive medical and surgical treatment, including antibiotics and debridement, to improve survival for this severe infection. While a small number of patients received hyperbaric oxygen therapy, the study does not provide enough detail to conclude its specific impact on outcomes.
Canadian Relevance
No direct Canadian connection identified.
Study Limitations
This study was a retrospective review conducted at a single institution, involving a small number of patients with craniocervical necrotizing fasciitis.